You are here

  • Home
  • Archive
  • Volume 79, Issue 8
  • Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone

Article info

Article menu

This article has a Reply. Please see:

Download PDFPDF

Correspondence
Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone
Free

Authors

  • Maxime Samson Department of Internal Medicine and Clinical Immunology, François Mitterrand Hospital, Dijon University Hospital, Dijon, France INSERM UMR1098, University of Burgundy, Dijon, France PubMed articlesGoogle scholar articles
  • Bernard Bonnotte Department of Internal Medicine and Clinical Immunology, François Mitterrand Hospital, Dijon University Hospital, Dijon, France INSERM UMR1098, University of Burgundy, Dijon, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Maxime Samson, Faculty of Medicine, INSERM UMR1098, University of Burgundy, Dijon 21078, France; samsonmaxime{at}gmail.com
View Full Text

Citation

Samson M, Bonnotte B
Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone
Annals of the Rheumatic Diseases 2020;79:e102.

Publication history

  • Received May 10, 2019
  • Accepted May 15, 2019
  • First published May 29, 2019.
Online issue publication 
July 13, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.